FY19 Topic Areas for the Peer Reviewed Cancer Research Program

*            Bladder cancer

*            Blood Cancers

*            Brain Cancer

*            Cancer in children, adolescents, and young adults1

*            Colorectal cancer

*            Immunotherapy2

*            Listeria vaccine for cancer

*            Liver cancer

*            Lymphoma

*            Mesothelioma

*            Neuroblastoma

*            Pancreatic cancer

*            Pediatric brain tumors

*            Rare cancers3

*            Stomach cancer

Funding for research into breast, kidney, lung, melanoma, ovarian, and prostate cancers is not allowed under the FY19 Peer Reviewed Cancer Research Program.

1The definition of adolescents and young adults is derived from the National Cancer Institute (https://www.cancer.gov/types/aya) and can be considered to be people between the ages of 15-39 years. Cancers studied under this Topic Area should be within the scope of the Congressional language and the intent of the Program Announcement(s). Research should be targeted toward children (ages 0-14 years), adolescents (ages 15-24 years) and/or young adults (ages 25-39 years).

2As derived from the National Cancer Institute Dictionary of Cancer terms (http://www.cancer.gov/publications/dictionaries/cancer-terms). Immunotherapy is a type of biological therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer. Cancers studied under this Topic Area should be within the scope of the Congressional language and the intent of the Program Announcement(s).

3Rare cancer is defined by the National Cancer Institute as a cancer that occurs in fewer than 15 out of 100,000 people each year (http://www.cancer.gov/publications/dictionaries/cancer-terms/def/791790). Cancers studied under this Topic Area should be within the scope of the Congressional language and the intent of the Program Announcement(s).

Jennie Mettert-Young

Public Affairs

For the USAMRMC, CDMRP

Ripple Effect

Fort Detrick, MD 21702-5024

Usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil

Book mark the CDMRP website:

cdmrp.army.mil

Follow CDMRP on Twitter at:

twitter.com/CDMRP

View CDMRP research results on YouTube:

www.youtube.com/user/CDMRP

Like us on FaceBook:

www.facebook.com/TheCDMRP